Plasma Fractionation Market Revenue to Reach $40.73Bn by 2028 at 6.3% CAGR with Immunoglobulin Segment Driving Growth During 2021–2028 | The Insight Partners
July 13, 2023 09:35 ET
|
The Insight Partners
Pune, India, July 13, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on “Plasma Fractionation Market Revenue Report, Forecast to 2028 – COVID-19 Impact and Global Analysis –...
Global Plasma Fractionation Market Anticipated to Garner $56,870.10 Million, Growing at a 7.2% CAGR in the 2022-2031 Timeframe [270-Pages] | Settled by Research Dive
June 07, 2023 09:05 ET
|
Research Dive
New York, USA, June 07, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global plasma fractionation market. According to the report, the global market is projected to...
Anti-Viral Therapies Market Growth ($82.92 Billion by 2028) Driven by Branded Drugs Segment during (2022-2028) – Global Report by The Insight Partners
March 09, 2023 08:46 ET
|
The Insight Partners
New York, March 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Anti-Viral Therapies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
Antiviral Drugs Market to Cross US$ 78 Bn in Revenues by the end of 2033 | According to Persistence Market Research
January 17, 2023 09:00 ET
|
Persistence Market Research
New York, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Reverse Transcriptase Inhibitors to account for Over 50% of the Antiviral Drugs Sales in the Forthcoming Years, Forecasts Persistence Market Research ...
Global Plasma Fractionation Market Envisioned to Generate a Revenue of $45,803.2 Million and Grow at a CAGR of 7.0% during the Forecast Period from 2020 to 2027 [165-Pages] | Published by Research DIve
August 29, 2022 09:03 ET
|
Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global plasma fractionation market is anticipated to generate a revenue of $45,803.2 million...
Cocrystal Pharma’s SARS-CoV-2 Main Protease Inhibitors Demonstrate Pan-viral Activity against Human Common Coronaviruses, Noroviruses, Rhinoviruses, and Enteroviruses
November 08, 2021 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that its SARS-CoV-2 main protease inhibitors showed potent in vitro...
Global Plasma Fractionation Market Set to Grow Immensely due to the Rising Demand for Plasma in the Treatment of Several Illnesses – Exclusive Report [165 Pages] By Research Dive
August 02, 2021 09:05 ET
|
Research Dive
New York, USA, Aug. 02, 2021 (GLOBE NEWSWIRE) -- According to the latest report by Research Dive, the global plasma fractionation market is anticipated to garner a revenue of $45,803.2 million by...
Global Plasma Fractionation Market set to Garner Revenue of $45,803.2 Million at a CAGR of 7.0% from 2020-2027 - Exclusive Report [Pages-165] by Research Dive
May 24, 2021 09:05 ET
|
Research Dive
New York, USA, May 24, 2021 (GLOBE NEWSWIRE) -- According to the latest estimates by Research Dive, the global plasma fractionation market is predicted to experience a rise in revenue from $25,404.5...
Antiviral Drugs Market revenue to cross USD 44.5 Bn by 2027: Global Market Insights Inc.
March 08, 2021 05:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, March 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Antiviral Drugs Market By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease...